These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 9081371

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours.
    Fridborg H, Jonsson B, Nygren P, Csoka K, Nilsson K, Oberg G, Kristensen J, Bergh J, Tholander B, Olsen L.
    Br J Cancer; 1994 Jul; 70(1):11-7. PubMed ID: 8018519
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
    van der Graaf WT, de Vries EG, Timmer-Bosscha H, Meersma GJ, Mesander G, Vellenga E, Mulder NH.
    Cancer Res; 1994 Oct 15; 54(20):5368-73. PubMed ID: 7923167
    [Abstract] [Full Text] [Related]

  • 9. Calcein-acetoxymethy ester enhances the antitumor effects of doxorubicin in nonsmall cell lung cancer by regulating the TopBP1/p53RR pathway.
    Lv Y, Liu R, Xie S, Zheng X, Mao J, Cai Y, Chen W.
    Anticancer Drugs; 2017 Sep 15; 28(8):861-868. PubMed ID: 28628491
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay.
    Tiberghien F, Loor F.
    Anticancer Drugs; 1996 Jul 15; 7(5):568-78. PubMed ID: 8862725
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Relationship between cytotoxic drug response patterns and activity of drug efflux transporters mediating multidrug resistance.
    Dhar S, Nygren P, Liminga G, Sundström C, de la Torre M, Nilsson K, Larsson R.
    Eur J Pharmacol; 1998 Apr 10; 346(2-3):315-22. PubMed ID: 9652375
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA).
    Larsson R, Kristensen J, Sandberg C, Nygren P.
    Int J Cancer; 1992 Jan 21; 50(2):177-85. PubMed ID: 1730510
    [Abstract] [Full Text] [Related]

  • 19. Antitumour activity of suramin analogues in human tumour cell lines and primary cultures of tumour cells from patients.
    Dhar S, Gullbo J, Csoka K, Eriksson E, Nilsson K, Nickel P, Larsson R, Nygren P.
    Eur J Cancer; 2000 Apr 21; 36(6):803-9. PubMed ID: 10762755
    [Abstract] [Full Text] [Related]

  • 20. Evaluation and comparison of MRP1 activity with three fluorescent dyes and three modulators in leukemic cell lines.
    Dogan AL, Legrand O, Faussat AM, Perrot JY, Marie JP.
    Leuk Res; 2004 Jun 21; 28(6):619-22. PubMed ID: 15120939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.